| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3376363 | Journal of Infection | 2008 | 4 Pages |
Abstract
At-risk populations, with high HIV prevalence and relatively low infant PCV7 immunization rates, may still be benefiting from PCV7-related herd protection effects.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Azadeh Tasslimi, Peter Wenger, Sri Ram Pentakota, Michael Brimacombe, Michele Burday, Anushua Sinha,